Safe use of proton-pump inhibitors

被引:2
作者
de Prados, Carlos Martin de Argila [1 ]
Cardona, Julia Lopez [1 ]
Arias, Federico Argueelles [2 ]
机构
[1] Hosp Univ Ramon y Cajal, Gastroenterol & Hepatol Dept, Madrid, Spain
[2] Univ Seville, Hosp Univ Virgen Macarena, Sch Med, Gastroenterol Dept, Seville, Spain
关键词
RISK; THERAPY;
D O I
10.17235/reed.2023.9834/2023
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
引用
收藏
页码:475 / 479
页数:5
相关论文
共 25 条
  • [1] Agencia Espanola de Medicamentos y Productos Sanitarios (AEMPS), 2011, Ref. MUH (FV)
  • [2] Castro LA, 2016, REV ESP ENFERM DIG, V108, P145, DOI 10.17235/reed.2015.3812/2015
  • [3] Long-term safety of proton pump inhibitor therapy assessed under controlled, randomised clinical trial conditions: data from the SOPRAN and LOTUS studies
    Attwood, S. E.
    Ell, C.
    Galmiche, J. P.
    Fiocca, R.
    Hatlebakk, J. G.
    Hasselgren, B.
    Langstrom, G.
    Jahreskog, M.
    Eklund, S.
    Lind, T.
    Lundell, L.
    [J]. ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2015, 41 (11) : 1162 - 1174
  • [4] An update on drug-drug interactions associated with proton pump inhibitors
    Ben Ghezala, Ines
    Luu, Maxime
    Bardou, Marc
    [J]. EXPERT OPINION ON DRUG METABOLISM & TOXICOLOGY, 2022, 18 (05) : 337 - 346
  • [5] Clopidogrel with or without Omeprazole in Coronary Artery Disease.
    Bhatt, Deepak L.
    Cryer, Byron L.
    Contant, Charles F.
    Cohen, Marc
    Lanas, Angel
    Schnitzer, Thomas J.
    Shook, Thomas L.
    Lapuerta, Pablo
    Goldsmith, Mark A.
    Laine, Loren
    Scirica, Benjamin M.
    Murphy, Sabina A.
    Cannon, Christopher P.
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2010, 363 (20) : 1909 - 1917
  • [6] Investigating potential confounding by indication when considering the association between proton pump inhibitor use, infection, hepatic encephalopathy and mortality in hospitalised decompensated cirrhosis: a post-hoc analysis of the ATTIRE trial
    China, Louise
    Tittanegro, Thais
    Crocombe, Dominic
    Forrest, Ewan
    Kallis, Yiannis
    Ryder, Stephen D.
    Wright, Gavin
    Freemantle, Nick
    O'Brien, Alastair
    [J]. ECLINICALMEDICINE, 2023, 58
  • [7] CHINZON Decio, 2022, Arq. Gastroenterol., V59, P219, DOI [10.1590/S0004-2803.202202000-40, 10.1590/s0004-2803.202202000-40]
  • [8] Safety and Complications of Long-Term Proton Pump Inhibitor Therapy: Getting Closer to the Truth
    Corley, Douglas A.
    [J]. GASTROENTEROLOGY, 2019, 157 (03) : 604 - 607
  • [9] Adverse effects of the proton pump inhibitors: review of evidences and position of the Spanish Society of Digestive Pathology
    de la Coba, Cristobal
    Arguelles-Arias, Federico
    Martin de Argila, Carlos
    Judez, Javier
    Linares, Antonio
    Ortega-Alonso, Aida
    Rodriguez, Enrique
    Rodriguez-Tellez, Manuel
    Vera, Isabel
    Aguilera, Lara
    Alvarez, Angel
    Andrade, Raul J.
    Bao, Fidencio
    Castro, Manuel
    Giganto, Froilan
    [J]. REVISTA ESPANOLA DE ENFERMEDADES DIGESTIVAS, 2016, 108 (04) : 207 - 224
  • [10] Proton pump inhibitors do not increase the risk of dementia: a systematic review and meta-analysis of prospective studies
    Desai, Madhav
    Nutalapati, Venkat
    Srinivasan, Sachin
    Fathallah, Jihan
    Dasari, Chandra
    Chandrasekhar, Viveksandeep Thoguluva
    Mohammad, Bilal
    Kohli, Divyanshoo
    Vaezi, Michael
    Katz, Philip O.
    Sharma, Prateek
    [J]. DISEASES OF THE ESOPHAGUS, 2020, 33 (10)